AI assistant
Sending…
Nexalin Technology, Inc. — Director's Dealing 2025
Jan 24, 2025
35042_dirs_2025-01-24_42c2f63b-df54-47fe-aec5-8815196ca877.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nexalin Technology, Inc. (NXL)
CIK: 0001527352
Period of Report: 2025-01-13
Reporting Person: Owens David (Director, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-13 | Common stock | P | 2000 | $2.50 | Acquired | 151293 | Direct |
| 2025-01-23 | Common stock | P | 1000 | $2.70 | Acquired | 152293 | Direct |
More from Nexalin Technology, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 22
Annual Report
2026
Mar 25
Regulatory Filings
2026
Feb 25
Regulatory Filings
2026
Jan 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23